These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 26652586

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Determination of avibactam and ceftazidime in human plasma samples by LC-MS.
    Sillén H, Mitchell R, Sleigh R, Mainwaring G, Catton K, Houghton R, Glendining K.
    Bioanalysis; 2015; 7(12):1423-34. PubMed ID: 26168250
    [Abstract] [Full Text] [Related]

  • 3. Quantification of piperacillin, tazobactam, meropenem, ceftazidime, and linezolid in human plasma by liquid chromatography/tandem mass spectrometry.
    Barco S, Bandettini R, Maffia A, Tripodi G, Castagnola E, Cangemi G.
    J Chemother; 2015; 27(6):343-7. PubMed ID: 25178412
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Selection and molecular characterization of ceftazidime/avibactam-resistant mutants in Pseudomonas aeruginosa strains containing derepressed AmpC.
    Lahiri SD, Walkup GK, Whiteaker JD, Palmer T, McCormack K, Tanudra MA, Nash TJ, Thresher J, Johnstone MR, Hajec L, Livchak S, McLaughlin RE, Alm RA.
    J Antimicrob Chemother; 2015; 70(6):1650-8. PubMed ID: 25645206
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ecological effect of ceftazidime/avibactam on the normal human intestinal microbiota.
    Rashid MU, Rosenborg S, Panagiotidis G, Löfdal KS, Weintraub A, Nord CE.
    Int J Antimicrob Agents; 2015 Jul; 46(1):60-5. PubMed ID: 25979639
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quantification of ceftazidime/avibactam in human plasma and dried blood spots: Implications on stability and sample transport.
    Martens-Lobenhoffer J, Angermair S, Bode-Böger SM.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Mar 15; 1193():123164. PubMed ID: 35196625
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z, Kayacan C, Oncul O.
    Int J Antimicrob Agents; 2012 Jan 15; 39(1):86-9. PubMed ID: 22041508
    [Abstract] [Full Text] [Related]

  • 13. Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimens.
    Nicolau DP, Siew L, Armstrong J, Li J, Edeki T, Learoyd M, Das S.
    J Antimicrob Chemother; 2015 Oct 15; 70(10):2862-9. PubMed ID: 26133566
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ceftolozane/tazobactam and ceftazidime/avibactam: two novel β-lactam/β-lactamase inhibitor combination agents for the treatment of resistant Gram-negative bacterial infections.
    Liscio JL, Mahoney MV, Hirsch EB.
    Int J Antimicrob Agents; 2015 Sep 15; 46(3):266-71. PubMed ID: 26143591
    [Abstract] [Full Text] [Related]

  • 19. Hydrogel-based fluorescence assay kit for simultaneous determination of ceftazidime and avibactam.
    Wang X, Du L, Zhang B, Li Y, Tao Z, Zhang L, Qu J, McFadden J, Qu H, Yang J, Liu J.
    Mikrochim Acta; 2024 Oct 16; 191(11):675. PubMed ID: 39414650
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.